The CMS’ long-awaited fix to repay hospitals for what the Supreme Court in 2022 determined to be years of underpayments in the 340B drug discount program is garnering a mixed reaction from hospital ...

Small business owners are struggling to keep up with the rising cost of healthcare. Nearly a third have recently stopped ...

Hospitals are suing to block a Trump administration pilot that will allow drugmakers to issue post-sale rebates instead of upfront discounts on medications in the 340B drug discount program, arguing ...

Minnesota's 340B drug discount program faces scrutiny as small clinics struggle and large hospitals profit, sparking ...

Oscar continues to show signs of improvement as revenues grow by 51% in Q1 Aanika Biosciences expands by 23,500 square feet in Industry City Hochul grants $7M for substance use treatment providers to ...

On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

Community-based practices are under increasing pressure to sell or close due to the unintended consequences of a rapidly ...

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.

All North Dakotans surely know the adage, “If it ain’t broke, don’t fix it.” Well, some North Dakota state lawmakers are test-driving a new concept: “If it is broke, pretend it’s not.” And the ...

A federal judge shows how this hospital ‘discount’ fleeces drug makers and patients.